On November 20, 2023, Generation Bio Co (NASDAQ: GBIO) opened at $1.19, higher 11.01% from the last session. During the day, the shares moved up to $1.31 and dropped to $1.165 before settling in for the closing price of $1.13. Price fluctuations for GBIO have ranged from $0.86 to $7.35 over the past 52 weeks.
Healthcare Sector giant saw their annual sales slid by -25.00% over the last five years. Company’s average yearly earnings per share was noted 19.67% at the time writing. With a float of $48.75 million, this company’s outstanding shares have now reached $59.51 million.
The firm has a total of 150 workers. Let’s measure their productivity.
Generation Bio Co (GBIO) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Generation Bio Co is 26.22%, while institutional ownership is 74.27%. The most recent insider transaction that took place on Aug 23, was worth 15,362. In this transaction CHIEF OPERATING OFFICER of this company sold 3,116 shares at a rate of $4.93, taking the stock ownership to the 2,914 shares. Before that another transaction happened on Jul 03, when Company’s CHIEF STRATEGY OFFICER sold 3,116 for $5.29, making the entire transaction worth $16,484. This insider now owns 101,428 shares in total.
Generation Bio Co (GBIO) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.43 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.5) by $0.07. This company achieved a return on equity of -41.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.49 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.67% per share during the next fiscal year.
Generation Bio Co (NASDAQ: GBIO) Trading Performance Indicators
Check out the current performance indicators for Generation Bio Co (GBIO). In the past quarter, the stock posted a quick ratio of 9.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 27.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.98, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Generation Bio Co (GBIO)
Analysing the last 5-days average volume posted by the [Generation Bio Co, GBIO], we can find that recorded value of 0.75 million was better than the volume posted last year of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 46.50%. Additionally, its Average True Range was 0.19.
During the past 100 days, Generation Bio Co’s (GBIO) raw stochastic average was set at 6.54%, which indicates a significant decrease from 68.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 159.24% in the past 14 days, which was higher than the 157.34% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.4264, while its 200-day Moving Average is $4.1347. Now, the first resistance to watch is $1.3250. This is followed by the second major resistance level at $1.3900. The third major resistance level sits at $1.4700. If the price goes on to break the first support level at $1.1800, it is likely to go to the next support level at $1.1000. Now, if the price goes above the second support level, the third support stands at $1.0350.
Generation Bio Co (NASDAQ: GBIO) Key Stats
There are currently 66,078K shares outstanding in the company with a market cap of 83.26 million. Presently, the company’s annual sales total 0 K according to its annual income of -136,640 K. Last quarter, the company’s sales amounted to 2,150 K and its income totaled -28,270 K.